The Maudsley Prescribing Guidelines
The DOI matches its Crossref record.
Abstract
Now entering its ninth edition, The Maudsley Prescribing Guidelines is the most widely used guide to psychiatric prescribing in the UK. The guidelines are an essential means by which psychiatrists and other healthcare professional stay current with the latest advances in prescribing. It provides practical advice for common clinical situations and i
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Still being checked.
Cited by
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Self-citationWalker, J., Hansen, C. H., Martin, P., Symeonides, S., Ramessur, R., Murray, G., & Sharpe, M. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70313-x · Cited by 435
“We defi ned potentially eff ective treatment as presently receiving an antidepressant drug at a minimal eff ective or higher dose (appendix p 6) 25 or presently visiting a mental health professional (psychiatrist or psychologist).”
Howes, O. D., Vergunst, F., Gee, S., McGuire, P., Kapur, S., & Taylor, D. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.105833 · Cited by 353
Self-citationFekadu, A., Wooderson, S. C., Markopoulo, K., Donaldson, C., Papadopoulos, A., & Cleare, A. J. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.10.014 · Cited by 299
Mota-Pereira, J., Silverio, J., Carvalho, S., Ribeiro, J. C., Fonte, D., & Ramos, J. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.02.005 · Cited by 257
Antidepressant-associated sexual dysfunction: impact, effects, and treatment
Higgins, A. (2010) · Drug, Healthcare and Patient Safety · doi:10.2147/dhps.s7634 · Cited by 227
Gafoor, R., Booth, H. P., & Gulliford, M. C. (2018) · BMJ · doi:10.1136/bmj.k1951 · Cited by 205
Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds
Whelan, P. J., & Remski, K. (2012) · Journal of Neurosciences in Rural Practice · doi:10.4103/0976-3147.91934 · Cited by 204
Antipsychotic Polypharmacy in Schizophrenia: Benefits and Risks
Barnes, T. R. E., & Paton, C. (2011) · CNS Drugs · doi:10.2165/11587810-000000000-00000 · Cited by 194
Self-citationA Systematic Review of Treatments for Refractory Depression in Older People
Cooper, C., Katona, C., Lyketsos, K., Blazer, D., Brodaty, H., Rabins, P., de Mendonça Lima, C. A., & Livingston, G. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10081165 · Cited by 176
Carvalho, L. A., Torre, J. P., Papadopoulos, A. S., Poon, L., Juruena, M. F., Markopoulou, K., Cleare, A. J., & Pariante, C. M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.036 · Cited by 167
White matter integrity as a predictor of response to treatment in first episode psychosis
Reis Marques, T., Taylor, H., Chaddock, C., Dell’Acqua, F., Handley, R., Reinders, A. A. T. S., Mondelli, V., Bonaccorso, S., DiForti, M., Simmons, A., et al. (2014) · Brain · doi:10.1093/brain/awt310 · Cited by 152
Hui, C. L. M., Honer, W. G., Lee, E. H. M., Chang, W. C., Chan, S. K. W., Chen, E. S. M., Pang, E. P. F., Lui, S. S. Y., Chung, D. W. S., Yeung, W. S., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30090-7 · Cited by 156
Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Gourley, C., Wall, L., Weller, D., Murray, G., & Sharpe, M. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70343-2 · Cited by 155
European Psychiatric Association (EPA) guidance on prevention of mental disorders
Campion, J., Bhui, K., & Bhugra, D. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.10.004 · Cited by 136
The common genetic liability between schizophrenia and bipolar disorder: A review.
Bramon, E., & Sham, P. C. (2001) · Current Psychiatry Reports · doi:10.1007/s11920-001-0030-1 · Cited by 150
Polypharmacy and excessive dosing: Psychiatrists' perceptions of antipsychotic drug prescription
Ito, H., Koyama, A., & Higuchi, T. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.187.3.243 · Cited by 142
Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management
Fanoe, S., Kristensen, D. E., Fink‐Jensen, A., Jensen, H. K., Toft, E., Nielsen, J., Videbech, P., Pehrson, S. M., & Bundgaard, H. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu100 · Cited by 142
Defining Treatment-Resistant Depression: A Comprehensive Review of the Literature
Trevino, K., McClintock, S. M., Fischer, N. M., Vora, A., & Husain, M. M. (2014) · Annals of Clinical Psychiatry · doi:10.1177/104012371402600310 · Cited by 130
“63 The minimum effective dose for these antidepressants is based on 2 commonly used prescription guidelines, the Antidepressant Treatment History Form 4 and the Maudsley Prescribing Guidelines.”
InfluentialCortical Folding Defects as Markers of Poor Treatment Response in First-Episode Psychosis
Palaniyappan, L. K., Marques, T. R., Taylor, H., Handley, R., Mondelli, V., Bonaccorso, S., Giordano, A., McQueen, G., Forti, M. D., Simmons, A., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.203 · Cited by 126
To combine or not to combine? A literature review of antidepressant combination therapy
Dodd, S., Horgan, D., Malhi, G. S., & Berk, M. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.08.012 · Cited by 110
Takeuchi, H., Suzuki, T., Uchida, H., Watanabe, K., & Mimura, M. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2011.11.021 · Cited by 115
“There are nine guidelines and algorithms that mentioned intermittent or targeted strategy (APA 2004; BAP, 2011; IPAP, 2004; Leucht et al., 2011; Taylor et al., 2009; NICE, 2009; PORT 2009; TMAP 2008; WFSBP 2006), and none of them endorsed such a strategy (Table 2).”
BackgroundResultInfluentialApproved and marketed nanoparticles for disease targeting and applications in COVID-19
Abdellatif, A. A. H., & Alsowinea, A. F. (2021) · Nanotechnology Reviews · doi:10.1515/ntrev-2021-0115 · Cited by 115
Salazar de Pablo, G., Pastor Jordá, C., Vaquerizo-Serrano, J., Moreno, C., Cabras, A., Arango, C., Hernández, P., Veenstra-VanderWeele, J., Simonoff, E., Fusar-Poli, P., et al. (2023) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2022.03.033 · Cited by 85
Antipsychotics and hyperprolactinaemia: Clinical recommendations
Peveler, R. C., Branford, D., Citrome, L., Fitzgerald, P., Harvey, P. W., Holt, R. I., Howard, L., Kohen, D., Jones, I., O'Keane, V., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107087346 · Cited by 93
Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management
Holt, R. I. G., & Peveler, R. C. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03814.x · Cited by 92
Taylor, D. M., & Smith, L. A. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01367.x · Cited by 102
Self-citationPsilocybin and MDMA for the treatment of trauma-related psychopathology
Bird, C. I. V., Modlin, N. L., & Rucker, J. J. H. (2021) · International Review of Psychiatry · doi:10.1080/09540261.2021.1919062 · Cited by 80
Castrignanò, E., Lubben, A., & Kasprzyk‐Hordern, B. (2016) · Journal of Chromatography A · doi:10.1016/j.chroma.2016.02.015 · Cited by 98
Keers, R. N., Plácido, M., Bennett, K., Clayton, K., Brown, P., & Ashcroft, D. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206233 · Cited by 97
Buhmann, C. B., Nordentoft, M., Ekstroem, M., Carlsson, J., & Mortensen, E. L. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.150961 · Cited by 92
Skandali, N., Rowe, J. B., Voon, V., Deakin, J. B., Cardinal, R. N., Cormack, F., Passamonti, L., Bevan-Jones, W. R., Regenthal, R., Chamberlain, S. R., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0229-z · Cited by 89
Maddock, C., Baita, A., Orrù, M. G., Sitzia, R., Costa, A., Muntoni, E., Farci, M. G., Carpiniello, B., & Pariante, C. M. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104040230 · Cited by 87
The hidden third: improving outcome in treatment-resistant depression
Schlaepfer, T. E., Ågren, H., Monteleone, P., Gasto, C., Pitchot, W., Rouillon, F., Nutt, D. J., & Kasper, S. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111431748 · Cited by 74
Attard, A., Ranjith, G., & Taylor, D. M. (2008) · CNS Drugs · doi:10.2165/00023210-200822080-00002 · Cited by 81
Self-citationPhysical health care monitoring for people with serious mental illness
Tosh, G. E., Clifton, A., Xia, J., & White, M. M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008298.pub3 · Cited by 81
Pindolol augmentation of antidepressant therapy
McAskill, R., Mir, S., & Taylor, D. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.3.203 · Cited by 81
Self-citationHaematological toxicity of clozapine and some other drugs used in psychiatry
Nooijen, P. M. M., Carvalho, F. D., & Flanagan, R. J. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1181 · Cited by 79
Prediction of longer-term outcome of treatment-resistant depression in tertiary care
Fekadu, A., Rane, L. J., Wooderson, S. C., Markopoulou, K., Poon, L., & Cleare, A. J. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.102665 · Cited by 77
Treatment of depression in adults with cancer: a systematic review of randomized controlled trials
Walker, J., Sawhney, A., Hansen, C. H., Ahmed, S., Martin, P., Symeonides, S., Murray, G., & Sharpe, M. (2014) · Psychological Medicine · doi:10.1017/s0033291713001372 · Cited by 67
Hyperinsulinemia: A unifying theory of chronic disease?
Crofts, C. A. P. (2015) · Diabesity · doi:10.15562/diabesity.2015.19 · Cited by 75
Jordan, S., Gabe‐Walters, M., Watkins, A. J., Humphreys, I., Newson, L. R., Snelgrove, S. R., & Dennis, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140203 · Cited by 75
Pharmacological interventions for clozapine-induced hypersalivation
Sheriff, R. S., Au, K., Cahill, C., Duggan, L., He, Y., Udu, V., & Xia, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005579.pub2 · Cited by 72
Fleeman, N., McLeod, C., Bagust, A., Beale, S., Boland, A., Dundar, Y., Jorgensen, A., Payne, K., Pirmohamed, M., Pushpakom, S. P., et al. (2010) · Health Technology Assessment · doi:10.3310/hta14030 · Cited by 72
Hynes, C., Keating, D., McWilliams, S., Madigan, K. V., Kinsella, A., Maidment, I., Feetam, C., Drake, R., Haddad, P. M., Gaughran, F., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.07.052 · Cited by 72
Shimomura, Y., Kikuchi, Y., Suzuki, T., Uchida, H., Mimura, M., & Takeuchi, H. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.09.013 · Cited by 72
Chung, A. K., & Chua, S.-E. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110376685 · Cited by 63
Combined use of clozapine and ECT: a review
Grover, S., Hazari, N., & Kate, N. (2015) · Acta Neuropsychiatrica · doi:10.1017/neu.2015.8 · Cited by 53
Kolp, E., Friedman, H. L., University of Florida, Krupitsky, E., St. Petersburg State Pavlov Medical University, Jansen, K., Hospital, A., Sylvester, M., Young, M. S., University of South Florida, et al. (2014) · International Journal of Transpersonal Studies · doi:10.24972/ijts.2014.33.2.84 · Cited by 54
Barnes, T. R., Leeson, V. C., Paton, C., Costelloe, C., Simon, J., Kiss, N., Osborn, D., Killaspy, H., Craig, T. K., Lewis, S., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20290 · Cited by 65
Self-citationToto, S., Grohmann, R., Bleich, S., Frieling, H., Maier, H. B., Greil, W., Cordes, J., Schmidt-Kraepelin, C., Kasper, S. F., Stübner, S., et al. (2019) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz037 · Cited by 65
Measurement and Management of QT Interval Prolongation for General Physicians
Indraratna, P., Tardo, D. T., Delves, M., Szirt, R., & Ng, B. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05477-7 · Cited by 64
Monitoring the Safe Use of Clozapine: A Consensus View from Victoria, Australia
Berk, M., Fitzsimons, J., Lambert, T., Pantelis, C., Kulkarni, J., Castle, D. J., Ryan, E. W., Jespersen, S., McGorry, P. D., Berger, G. E., et al. (2007) · CNS Drugs · doi:10.2165/00023210-200721020-00003 · Cited by 64
Safety of antipsychotics in people with intellectual disability
Frighi, V., Stephenson, M. T., Morovat, A., Jolley, I. E., Trivella, M., Dudley, C. A., Anand, E., White, S. J., Hammond, C. V., Hockney, R. A., et al. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.110.085670 · Cited by 63
Bushe, C. J., Bradley, A. J., Doshi, S., & Karagianis, J. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02224.x · Cited by 56
Sexual dysfunction in people with prodromal or first-episode psychosis
Marques, T. R., Smith, S. M., Bonaccorso, S., Gaughran, F., Kolliakou, A., Dazzan, P., Mondelli, V., Taylor, H., Forti, M. D., McGuire, P. K., et al. (2012) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.101220 · Cited by 61
Talarowska, M. E., Gałecki, P., Maes, M. H. J., Gardner, A., Chamielec, M., Orzechowska, A., Bobińska, K., & Kowalczyk, E. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1335-8 · Cited by 61
Assessment of subjective cognitive and emotional effects of antipsychotic drugs. Effect by defect?
Moritz, S., Andreou, C., Klingberg, S., Thoering, T., & Peters, M. J. V. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.039 · Cited by 60
Clinical practice guidelines for autism spectrum disorders
Subramanyam, A., Mukherjee, A., Dave, M., & Chavda, K. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_542_18 · Cited by 59
Antipsychotic polypharmacy – confusion reigns
Taylor, D. M. (2010) · The Psychiatrist · doi:10.1192/pb.bp.109.027086 · Cited by 58
Self-citationOnce-monthly paliperidone injection for the treatment of schizophrenia
Bishara, D. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s8505 · Cited by 58
Sachdeva, A., Chandra, M., & Deshpande, S. N. (2014) · Alcohol and Alcoholism · doi:10.1093/alcalc/agt181 · Cited by 56
Risk of venous thromboembolism during treatment with antipsychotic agents
Masopust, J., Malý, R., & Vališ, M. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12001 · Cited by 56
Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
Yogaratnam, J., Biswas, N., Vadivel, R., & Jacob, R. (2013) · PubMed · Cited by 55
Brunero, S., & Lamont, S. (2009) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2009.11.004 · Cited by 55
Antipsychotic polypharmacy: review of mechanisms, mortality and management
Langan, J., & Shajahan, P. M. (2010) · The Psychiatrist · doi:10.1192/pb.bp.108.024257 · Cited by 55
Antipsychotic Polypharmacy in Inpatients with Schizophrenia in Asia (2001−2009)
Xiang, Y., Wang, C., Si, T., Lee, E. H. M., He, Y. L., Ungvari, G., Chiu, H. F., Yang, S., Chong, M., Tan, C. H., et al. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1286345 · Cited by 54
Petrie, B., Youdan, J., Barden, R., & Kasprzyk‐Hordern, B. (2016) · Environmental Science & Technology · doi:10.1021/acs.est.6b00291 · Cited by 54
Bushe, C. J., Bradley, A., & Pendlebury, J. (2010) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2010.010025 · Cited by 48
Bigliani, V., Mulligan, R. S., Acton, P. D., Visvikis, D., Ell, P. J., Stephenson, C., Kerwin, R. W., & Pilowsky, L. S. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.3.231 · Cited by 47
Self-citationVieta, E., Owen, R., Baudelet, C., McQuade, R. D., Sanchez, R., & Marcus, R. N. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003779380 · Cited by 53
Review of smoking cessation treatments for people with mental illness
Campion, J., Checinski, K., & Nurse, J. (2008) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.107.003483 · Cited by 43
Baandrup, L., Allerup, P., Lublin, H., Nordentoft, M., Peacock, L., & Glenthoj, B. Y. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01553.x · Cited by 50
Lee, M.-J., Shin, Y.-B., Sunwoo, Y.-K., Jung, S.-H., Kim, W.-H., Kang, M.-H., Lee, J.-S., Bae, J.-N., & Kim, C.-E. (2009) · Psychiatry Investigation · doi:10.4306/pi.2009.6.4.286 · Cited by 49
A survey of the off-label use of mood stabilizers in a large psychiatric hospital
Haw, C., & Stubbs, J. H. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105053307 · Cited by 49
Jordan, S. E., Davies, G. I., Thayer, D. S., Tucker, D., & Humphreys, I. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225133 · Cited by 48
Hou, C., Zang, Y., Rosen, R. C., Cai, M.-Y., Li, Y., Jia, F., Lin, Y.-Q., Ungvari, G. S., Ng, C. H., Chiu, H. F. K., et al. (2015) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2015.11.002 · Cited by 48
Managing depression in physical illness
MacHale, S. (2002) · Advances in Psychiatric Treatment · doi:10.1192/apt.8.4.297 · Cited by 48
Nyboe, L., Vestergaard, C. H., Moeller, M. K., Lund, H., & Videbech, P. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.07.053 · Cited by 47
Haw, C., & Stubbs, J. H. (2010) · International Psychogeriatrics · doi:10.1017/s1041610209991669 · Cited by 47
Li, Q., Xiang, Y., Su, Y., Shu, L., Yu, X., Chiu, H. F. K., Correll, C. U., Ungvari, G. S., Lai, K. Y. C., Ma, C., et al. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414536931 · Cited by 45
Russell, A., Ciufolini, S., Gardner-Sood, P., Bonaccorso, S., Gaughran, F., Dazzan, P., Pariante, C. M., & Mondelli, V. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.004 · Cited by 44
An observational study of clozapine induced sedation and its pharmacological management
Perdigues, S. R., Sauras-Quetcuti, R. B., Mané, A., Mann, L., Mundell, C., & Fernández-Egea, E. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.006 · Cited by 44
Sridhar, S. B., Al-Thamer, S. F., & Jabbar, R. (2016) · Journal of Basic and Clinical Pharmacy · doi:10.4103/0976-0105.183263 · Cited by 43
Organ transplant & the psychiatrist: An overview
Mattoo, S., & Kumar, B. A. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.159268 · Cited by 42
Hepatotoxicity induced by clozapine: a case report and review of literature
Wu, Lu, M., & Shen, W. W. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s67654 · Cited by 42
Improving the physical health of long-stay psychiatric in-patients
Cormac, I., Martin, D. M., & Ferriter, M. (2004) · Advances in Psychiatric Treatment · doi:10.1192/apt.10.2.107 · Cited by 41
Scanlon, C., Anderson‐Schmidt, H., Kilmartin, L., McInerney, S. J., Kenney, J. P. M., Mcfarland, J. W., Waldron, M., Ambati, S., Fullard, A. C., Logan, S., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.07.030 · Cited by 40
Treatment of depression in people with lung cancer: A systematic review
Walker, J., Sawhney, A., Hansen, C. H., Symeonides, S. N., Martin, P., Murray, G. D., & Sharpe, M. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.09.014 · Cited by 40
Bowskill, S. V. J., Couchman, L., MacCabe, J. H., & Flanagan, R. J. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2223 · Cited by 40
Facial emotion recognition in Chinese with schizophrenia at early and chronic stages of illness
Leung, J. S. Y., Lee, T. M. C., & Lee, C. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.07.001 · Cited by 40
Delay in initiation of clozapine: A retrospective study from a tertiary care hospital in North India
Grover, S., Hazari, N., Chakrabarti, S., & Avasthi, A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.12.046 · Cited by 40
Percudani, M., Barbui, C., & Tansella, M. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422110-00002 · Cited by 40
Shimomura, Y., Kikuchi, Y., Suzuki, T., Uchida, H., Mimura, M., & Takeuchi, H. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.07.040 · Cited by 39
Positioning mental health nursing practice within a positive health paradigm
Wand, T. (2012) · International Journal of Mental Health Nursing · doi:10.1111/j.1447-0349.2012.00848.x · Cited by 38
Wand, T., & Murray, L. (2008) · International Journal of Mental Health Nursing · doi:10.1111/j.1447-0349.2008.00559.x · Cited by 37
Ponsford, M., Steven, R., Bramhall, K., Burgess, M., Wijetilleka, S., Carne, E. M., McGuire, F., Price, C. R., Moody, M., Zouwail, S., et al. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2019-206235 · Cited by 37
Hindle, J. V. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-0994-0 · Cited by 36
Jordan, S. E., Gabe, M., Newson, L. R., Snelgrove, S. R., Panes, G., Picek, A., Russell, I. T., & Dennis, M. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/843621 · Cited by 36
Metadata
- Authors
- Taylor, D., Paton, C., & Kerwin, R.
- Affiliations
- Oxleas NHS Foundation Trust (GB)
- Venue
- CRC Press eBooks
- Publisher
- CRC Press
- Published
- 2007-05-31
- OpenAlex
- W1010755848
- Cited by
- 366
- References
- 0
- Citations by year
- 2023: 3 · 2022: 3 · 2021: 8 · 2020: 11 · 2019: 7 · 2018: 13 · 2017: 5 · 2016: 15 · 2015: 19 · 2014: 31 · 2013: 27 · 2012: 31
- Type
- reference entry
- Language
- en
- Open access
- closed
- Locations
- CRC Press eBooks (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- psychiatric prescribing, prescribing guidelines, antipsychotic drugs, psychotropic drugs, clinical guidelines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.